Pilot Trial of Hydroxychloroquine as Add-On Therapy in Patients With Membranous Nephropathy
Authors
- Beiru Zhang
- Feng Du (ORCID: https://orcid.org/0000-0003-0333-2687)
- Junjun Luan
- Congcong Jiao (ORCID: https://orcid.org/0000-0002-9096-8431)
- Hua Zhou (ORCID: https://orcid.org/0000-0001-6508-7942)
- Jeffrey B. Kopp (ORCID: https://orcid.org/0000-0001-9052-186X)
- Guangping Sun (ORCID: https://orcid.org/0000-0002-8334-4153)
- Hong‐Yu Yang (ORCID: https://orcid.org/0000-0003-2141-5814)
- Xu Yang (ORCID: https://orcid.org/0009-0004-2734-3203)
- Qingbin Song (ORCID: https://orcid.org/0009-0009-9830-9690)
- Yanqiu Wang (ORCID: https://orcid.org/0000-0002-4073-598X)
Institutions
- National Institutes of Health (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- China Medical University (CN)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1016/j.ekir.2024.09.016
- Citations
- 3
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.02
Funders
- China Medical University
- National Institutes of Health
- Shengjing Hospital
- National Institute of Diabetes and Digestive and Kidney Diseases